Across TCGA pan-cancer cohorts, PPP1CC Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated PPP1CC data layer compared with 25 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PPP1CC Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PPP1CC expression acts as an unfavorable survival marker.

HNSC, KICH, and LUSC are the cancer types where PPP1CC Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.162	0.712	<.001	42	view →
KICH	DFS	Median	All	0.081	0.904	<.001	30	view →
LUSC	OS	Median	All	0.159	0.675	.015	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: PPP1CC tumor-vs-normal RNA expression · all PPP1CC data types